Patients with CLL demonstrating deletion of 11q or 17p, high expression of ZAP70 or CD38, or relative absence of V region somatic hypermutation have markers that indicate more aggressive disease. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.